AU2001273318A1 - Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders - Google Patents
Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disordersInfo
- Publication number
- AU2001273318A1 AU2001273318A1 AU2001273318A AU7331801A AU2001273318A1 AU 2001273318 A1 AU2001273318 A1 AU 2001273318A1 AU 2001273318 A AU2001273318 A AU 2001273318A AU 7331801 A AU7331801 A AU 7331801A AU 2001273318 A1 AU2001273318 A1 AU 2001273318A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosing
- disorders
- compositions
- methods
- treating preeclampsia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21665700P | 2000-07-07 | 2000-07-07 | |
US60/216,657 | 2000-07-07 | ||
PCT/US2001/021719 WO2002004678A2 (en) | 2000-07-07 | 2001-07-09 | Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001273318A1 true AU2001273318A1 (en) | 2002-01-21 |
Family
ID=22807962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001273318A Abandoned AU2001273318A1 (en) | 2000-07-07 | 2001-07-09 | Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020102530A1 (en) |
AU (1) | AU2001273318A1 (en) |
WO (1) | WO2002004678A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100379882C (en) * | 2003-01-17 | 2008-04-09 | 香港中文大学 | Circulating mRNA as diagnostic markers for pregnancy-related disorders |
WO2005017192A2 (en) * | 2003-08-14 | 2005-02-24 | The General Hospital Corporation | Screening for gestational disorders |
CA2539430C (en) * | 2003-09-23 | 2015-03-17 | The General Hospital Corporation | Screening for gestational disorders with sex hormone binding globulin as biomarker |
EP1773349A4 (en) | 2004-05-04 | 2009-07-29 | Childrens Medical Center | Methods and compositions for treatment of preeclampsia |
WO2006069592A2 (en) * | 2004-12-31 | 2006-07-06 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg | Method for diagnosing an/or predicting preeclampsia and/or related disorders |
JP5629051B2 (en) * | 2005-03-18 | 2014-11-19 | ザ チャイニーズ ユニバーシティー オブ ホンコンThe Chinese University Of Hongkong | Markers for prenatal diagnosis and monitoring |
US20060212484A1 (en) * | 2005-03-18 | 2006-09-21 | Chaffin David G Jr | System and method for evaluating, monitoring, diagnosing, and treating hypertension and other medical disorders |
EP1914552A1 (en) * | 2006-10-20 | 2008-04-23 | The University Of Newcastle Research Associates Limited | Method for identifying women with an increased risk of pre-eclampsia |
WO2008134881A1 (en) * | 2007-05-05 | 2008-11-13 | The University Of Western Ontario | Methods for the detection of preeclampsia |
EP3309178A4 (en) | 2015-06-11 | 2019-05-08 | Keio University | Fusion protein or conjugated protein, intracellular delivery carrier, partial peptide, cell membrane permeation enhancer, dna, and vector |
CN112180098B (en) * | 2019-12-06 | 2023-02-17 | 中山大学 | Screening method of placenta-related disease marker and marker |
WO2021207168A1 (en) * | 2020-04-06 | 2021-10-14 | The Trustees Of The University Of Pennsylvania | Methods for using extracellular micro vesicles with syncytiotrophoblast markers to diagnose preeclampsia |
CN113528646A (en) * | 2021-07-22 | 2021-10-22 | 青岛思拓新源细胞医学有限公司 | Diagnosis marker for preeclampsia and application of diagnosis marker in preparation of target spot medicine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1000158B1 (en) * | 1997-07-07 | 2006-11-22 | Bio Merieux | Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
FR2797889A1 (en) * | 1999-09-01 | 2001-03-02 | Bio Merieux | METHOD FOR DETECTING THE EXPRESSION OF ENVELOPE PROTEIN FROM A HUMAN ENDOGENEOUS RETROVIRUS AND USES OF A GENE ENCODING SAME |
-
2001
- 2001-07-09 WO PCT/US2001/021719 patent/WO2002004678A2/en not_active Application Discontinuation
- 2001-07-09 AU AU2001273318A patent/AU2001273318A1/en not_active Abandoned
- 2001-07-09 US US09/902,535 patent/US20020102530A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20020102530A1 (en) | 2002-08-01 |
WO2002004678A2 (en) | 2002-01-17 |
WO2002004678A3 (en) | 2003-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005046434A8 (en) | Compositions and methods for diagnosing and treating mental disorders | |
AU2003238561A1 (en) | Compositions and methods for treating gynaecological disorders | |
AU2001285159A1 (en) | Methods for treating endocrine disorders | |
AU8003800A (en) | Methods and compositions for treating neurobehavioral disorders | |
AU2002340120A1 (en) | Semisolid topical hormonal compositions and methods for treatment | |
AU2001247893A1 (en) | Method for facilitating commercial transactions | |
AU2001284865A1 (en) | Methods for diagnosing and treating dysautonomia and other dysautonomic conditions | |
AU2001245977A1 (en) | Method and composition for preventing or reducing the symptoms of menopause | |
AU2001273318A1 (en) | Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders | |
AU2001251391A1 (en) | Compositions and methods for promoting neural regeneration | |
AU2001286750A1 (en) | Compositions and methods for exon profiling | |
WO2003039490A9 (en) | Compositions and methods for diagnosing and treating mental disorders | |
AU2001289123A1 (en) | Compounds and methods for diagnosing and treating amyloid-related conditions | |
AU2001251507A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
ZA200610474B (en) | Compositions and methods for treating inflammatory disorders | |
AU4515001A (en) | Compositions and methods for locally treating inflammatory diseases | |
AU2003301348A1 (en) | Compositions and methods for diagnosing and treating autoimmune disease | |
AU2002229733A1 (en) | Methods and reagents for treating autoimmune disorders | |
AU2003214920A1 (en) | Methods and compositions for treating hematological disorders | |
AU2001251508A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
AU2001256998A1 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
AU2002227837A1 (en) | Method and system for diagnosing andropause in males | |
AU2001238288A1 (en) | Method and compositions for treating fibrotic diseases | |
AUPQ872800A0 (en) | Compositions and methods for treating cardiovascular disorders | |
AU2002217915A1 (en) | Compositions and methods for diagnosing or treating psoriasis |